Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,276,767 papers from all fields of science
Search
Sign In
Create Free Account
Aromatase Inhibitors
Known as:
Androstenedione Aromatase Inhibitor
, Estrogen Synthase Inhibitor
, Estrogen Synthetase Inhibitor
Expand
Any substance that inhibits aromatase, an enzyme responsible for the conversion of cholesterol to pregnenolone and the peripheral aromatization of…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
15 relations
Narrower (9)
Aminoglutethimide
Fadrozole
anastrozole
exemestane
Expand
Broader (1)
Enzyme Inhibitors
Estrogen Antagonists
In Blood
aspects of radiation effects
chemical synthesis
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Aromatase inhibitor-induced arthralgia: a review.
Polly A. Niravath
Annals of Oncology
2013
Corpus ID: 3219332
Though aromatase inhibitors (AIs) are an essential part of estrogen receptor-positive (ER+) breast cancer therapy, many patients…
Expand
Highly Cited
2009
Highly Cited
2009
Successful fertility treatment for Klinefelter's syndrome.
R. Ramasamy
,
J. Ricci
,
G. Palermo
,
L. Gosden
,
Z. Rosenwaks
,
P. Schlegel
Journal of Urology
2009
Corpus ID: 27003250
Review
2007
Review
2007
Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.
L. Gibson
,
C. Dawson
,
D. Lawrence
,
J. Bliss
Cochrane Database of Systematic Reviews
2007
Corpus ID: 32889631
BACKGROUND Hormonal treatments for advanced or metastatic breast cancer, such as tamoxifen and the progestins megestrol acetate…
Expand
Review
2007
Review
2007
The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancer
C. Fabian
International journal of clinical practice
2007
Corpus ID: 17323258
The third‐generation aromatase inhibitors (AIs) anastrozole, exemestane and letrozole have largely replaced tamoxifen as the…
Expand
Review
2007
Review
2007
Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.
R. D. Bruno
,
V. Njar
Bioorganic & Medicinal Chemistry
2007
Corpus ID: 23394141
Highly Cited
2006
Highly Cited
2006
Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis.
D. Mauri
,
N. Pavlidis
,
N. Polyzos
,
J. Ioannidis
Journal of the National Cancer Institute
2006
Corpus ID: 9309428
BACKGROUND Aromatase inhibitors and inactivators have been extensively tested in patients with advanced breast cancer, but it is…
Expand
Review
2006
Review
2006
Aromatase and other steroidogenic genes in endometriosis: translational aspects.
E. Attar
,
S. Bulun
Human Reproduction Update
2006
Corpus ID: 14427485
Endometriosis is a common, chronic and estrogen-dependent gynaecological disorder associated with pelvic pain and infertility. In…
Expand
Highly Cited
2005
Highly Cited
2005
Aromatase inhibitors in human lung cancer therapy.
O. Weinberg
,
D. Márquez-Garbán
,
+4 authors
R. Pietras
Cancer Research
2005
Corpus ID: 13363836
Lung cancer is the most common cancer in the world. It is a highly lethal disease in women and men, and new treatments are…
Expand
Review
2001
Review
2001
Aromatase, Aromatase Inhibitors, and Breast Cancer
R. Brueggemeier
American Journal of Therapeutics
2001
Corpus ID: 8528177
Estrogens are involved in numerous physiologic processes and have crucial roles in particular disease states, such as mammary…
Expand
Highly Cited
1997
Highly Cited
1997
Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium.
J. Kitawaki
,
T. Noguchi
,
+6 authors
Hideo Honjo
Biology of Reproduction
1997
Corpus ID: 24230331
To determine whether local estrogen production takes place in endometriotic or adenomyotic tissues, in eutopic endometrium from…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE